Subependymal giant cell astrocytomas (SEGAs) | Developmental Synaptopathies Consortium

Skip to main content

Search

Join Our Contact Registry

Header Social Media

Main navigation

Our Research
Patients and Families
Researchers and Clinicians
Early Stage Investigators
News and Events
- Latest News
- Past Events
About Us

An NIH-Funded Rare Diseases Clinical Research Network Consortium

Tumor-like lesions in the brain that have grown and if left untreated, can cause hydrocephalus.

Footer menu

Contact Us
Genetic and Rare Diseases Information Center
Members Login
Rare Diseases Clinical Research Network
Website policies
Sitemap

The Developmental Synaptopathies Consortium (DSC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). DSC is funded under grant number U54NS092090 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute on Deafness and Other Communication Disorders (NIDCD). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the DSC administrative coordinating center at Boston Children’s Hospital and does not necessarily represent the official views of the NIH.

social media